Drug recall D-0531-2024
Product
EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Glass Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01, NDC (sample lot) 61755-005-54
Reason for recall
Lack of Assurance of Sterility: Complaints of syringe breakage
Lots and codes
Lot # 8231500321, Exp. date Oct-24 8231500335, Exp. date Jan-25 8231500333, Exp. date Jan-25 8231500334, Exp. date Jan-25 8231500339, Exp. date Jan-25 8231500347, Exp. date Jan-25 8231500336, Exp. date Jan-25 8231500337, Exp. date Jan-25 8231500340, Exp. date Jan-25 8268700014 (sample lot) exp. date Jan-25
Recall details
- Recalling firm
- Regeneron Pharmaceuticals Inc, Tarrytown, NY
- Quantity
- 405,725 Prefilled syringes
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 15, 2024
- Terminated
- September 25, 2025
Related products
- Eylea – drug information
- NDC 61755-005 Eylea · Aflibercept 40 mg/mL · Regeneron Pharmaceuticals, Inc.